-The Business Standard The new price caps for 191 essential drugs are likely to introduce serious distortions in the market for these medicines The National Pharmaceutical Pricing Authority, or NPPA, has announced new price caps for 191 essential drugs that are 10 to 50 per cent lower than the current prices. Drug makers have 45 days to recall the earlier batches and send out new ones with the lower price tags. This...

-Grist Media The proposed Food Security Bill will likely raise the demand for dal across India. While farmers and consumers are against it, the government keeps favouring the agri-industry and importing more and more cheap versions to offset rising inflation. But why won't India produce its own dal anymore? Nowhere are Canada's agricultural production plans tracked more closely than in India's Ministry of Food & Consumer Affairs. As it struggles to meet...

-The Telegraph Kolkata: Two books by celebrated economists have set the stage for an absorbing growth battle. Columbia University professor Jagdish Bhagwati and Nobel laureate Amartya Sen want the same end - a better India - but the means they prescribe sound different. If Bhagwati prescribes economic growth led by the markets and overseen and encouraged by liberal state policies, Sen believes growth cannot be an end in itself without government effort to...

-The Hindu     The much-awaited Drug (Prices Control) Order 2013 has disappointed millions of patients, as it lacks a fair formula to fix the price ceiling and leaves important drug classes out of regulation. The result: High out-of-pocket spending on medicines will continue As far as intentions go, the Drug (Prices Control) Order 2013 is aimed at making critical drugs affordable and available to the public, while preserving a rationale for manufacture by...

-The Hindu The current market prices are essentially over and above the actual cost of production - a difference that could run from 100 per cent to 5,600 per cent, depending upon various therapeutic categories In a liberalised market economy, do we need price controls on drugs? Policymakers and the pharmaceutical industry do not think so. They believe that price controls are an inefficient tool that distorts resource allocation, squeezes revenue, reduces...